Dr Reddy's submits Indian trials data of Sputnik to DCGI

Dr Reddy’s Laboratories, which has applied for emergency use authorisation (EUA) for Russian Covid-19 vaccine Sputnik V, has submitted data from the Indian Phase II/III trials as directed by the expert committee that advises the Indian drug regulator. The Indian trials data sought by the Drug Controller General of India (DCGI) was submitted last week and the company is now waiting to present it before the expert committee that is slated to meet this week, sources said.
Read more...

;